UnitedHealth Group Incorporated $UNH Stake Lowered by ASR Vermogensbeheer N.V.

Key Points

• ASR Vermogensbeheer cut its UNH stake by 3.4% in Q4 to 202,597 shares worth $66.88 million, making UnitedHealth its 16th-largest holding and 0.8% of the firm's portfolio.
• Quarterly beat and guidance: UnitedHealth reported EPS of $7.23 vs. $6.76 expected and $111.65 billion in revenue, set FY2026 EPS guidance around $18.25, and carries a consensus analyst price target near $378.88.
• Operationally positive: Management plans to eliminate prior authorization for roughly 30% of services to lower administrative costs and speed care, and investor-friendly actions (share buybacks) plus analyst upgrades have supported a constructive market narrative.

ASR Vermogensbeheer N.V. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 202,597 shares of the healthcare conglomerate's stock after selling 7,198 shares during the period. UnitedHealth Group accounts for 0.8% of ASR Vermogensbeheer N.V.'s investment portfolio, making the stock its 16th biggest holding. ASR Vermogensbeheer N.V.'s holdings in UnitedHealth Group were worth $66,880,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group in the fourth quarter worth $26,000. Joseph Group Capital Management bought a new stake in UnitedHealth Group in the fourth quarter worth $27,000. Foster Dykema Cabot & Partners LLC boosted its holdings in UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 34 shares in the last quarter. 1248 Management LLC bought a new stake in UnitedHealth Group in the third quarter worth $29,000. Finally, Holos Integrated Wealth LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $29,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth announced it will eliminate prior authorization for roughly 30% of services, a move management says will reduce paperwork, speed care and lower administrative costs — a structural change investors view as margin-accretive and goodwill-building with providers and members. UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services
• Positive Sentiment: Analysis pieces highlight a recovery in utilization and operating leverage that could support further upside in UNH’s health benefits margins and earnings trajectory. This narrative helps justify recent multiple expansion. UnitedHealth: Watch The Recovery In Action
• Positive Sentiment: Investor-focused write-ups point to share buybacks and valuation metrics that suggest management sees shares as undervalued — buybacks tend to be viewed as shareholder-friendly and can support EPS. According to These Metrics, UnitedHealth Stock Looks Undervalued
• Neutral Sentiment: Zacks' reporting shows a mix of estimate changes: some near-term quarters and FY2026 estimates were raised while several future-quarter and FY2027/FY2028 projections were trimmed — the net effect is mixed guidance signal and increased forecast volatility. Bullish Quarterly Results: 3 Companies Raising Guidance
• Neutral Sentiment: Peer results: CVS and Tenet reported stronger-than-expected operating trends (CVS’s Health Benefits segment saw large operating income gains). Strong peer performance underscores competitive dynamics in the benefits market — good for sector fundamentals but a mixed read for UNH’s market share and pricing. CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
• Negative Sentiment: Some Zacks notes lowered specific quarter estimates (examples: downward revisions to Q4 FY2026 and Q4 FY2027 estimates), which introduces short-term earnings risk and could temper upside if revisions continue. (Source: Zacks/analyst notes summarized in market reports.)

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares of the company's stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 7th. Argus raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price objective for the company in a research report on Wednesday, April 22nd. Mizuho lowered their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a research note on Thursday, February 5th. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a "buy" rating in a research note on Monday, April 20th. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $327.00 to $373.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $378.88.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $369.65 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $390.92. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm's 50-day moving average price is $304.54 and its two-hundred day moving average price is $316.98. The stock has a market capitalization of $335.70 billion, a price-to-earnings ratio of 27.92, a P/E/G ratio of 1.58 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion for the quarter, compared to analysts' expectations of $109.84 billion. During the same period in the prior year, the firm earned $7.20 earnings per share. UnitedHealth Group's revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group's dividend payout ratio is 66.77%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.